Medical network May 12 - Liang Wannian said at the meeting, not long ago, national health development planning commission jointly with relevant departments specializing in the "about a shortage of medicine supply security" problem, this file will be printed and distributed in the near future. 

 

A shortage of drugs that has plagued the market for years will come out. 

 

Yesterday, the national health and family planning commission held a "special conference on deepening health care reform in 2017" to interpret the focus of deepening reform in 2017. 

 

The problem has also been one of the focus of yesterday's conference due to the recent problems with the shortage of 1,004 products in guangdong. 

 

National health development planning commission meeting yesterday, the national health development planning commission TiGaiSi chief priests Liang Wannian revealed that will introduce relevant documents about the shortage of medicine supply guarantee, graded response by way of warning. 

 

Liang said that the issue of drug supply protection has been an important task for healthcare reform. Drug supply problems in the supply of security system is a key ring, the core problem is the guarantee drug can satisfy the demand, and to timely, ensure the quality at the same time. 

 

Liang Wannian said, China's drug types used by more and more manufacturers, distribution companies are also more, our suppliers at the same time, the medical and health service system, with the number of hospitals is the most of the world. "A system of supply and demand that is so large, and how to work together effectively, is really a matter of planning and reform." 

 

In the supply sector, he says, the key is to protect the shortage. He revealed that shortly before, the national health and family planning commission (NHFPC) had been working with the relevant departments to study the issue of "supply protection for shortages", which will soon be printed. 

 

"In drug supply security, we must establish a kind of medicine supply shortage of security, including coping mechanisms, from how to find what kind of medicine is shortage, found that after carefully analyse the causes of it, for early warning." After the warning, according to the nature of the classification, the analysis of the causes of production causes the shortage. What are the causes of the shortage for the price? What could be a seasonal cause? What are the supply problems of raw materials? After analyzing the various factors, different approaches are taken to respond to the extent and extent of the analysis. 

 

Drug trading center in guangdong province has promulgated the drug trade in the fifth batch of supply is not in accordance with the contract and not timely supply enterprises, pointed out that based on complaints, medical institutions in guangdong province, a total of 1004 product rules of drugs not supply or supply not in time. There are about 70 percent of the drug companies that have been involved in the drug industry. 

 

Public information display, April 18, President xi jinping hosted central comprehensively deepen reform leading group 34 times will emphasize, drug supply security mechanism, reform and improve the shortage to designated production, coordinate emergency production and imports, improve the shortage of pharmaceutical reserve, through drugs research and development, production, distribution, purchasing, etc. 

 

Reform in 2017, the key task of drug supply security system construction as one of important 56 task, further expanding the scope of the drug shortage of fixed-point production, support the construction of small breed drug centralized production base, establish and improve the shortage of drug monitoring and early warning and response system classification. 

 

Before this in December 2016, the national health and family planning commission has issued a "about 2016 clinical drugs, dosage is small, the market supply shortage of necessary designated production pilot related matters notice, the ministry of industry and information technology, the national health and family planning commission, the national development and reform commission, the state drug supervision administration organized the 2016 clinical required, small dosage, fixed-point production pilot shortage medicines on the market, has now completed digoxin oral solution, compound sulfamethoxazole injection, three varieties of amino acid sodium for injection, the designated production enterprise of the bidding work.